Do you
categorize patients as having mild, moderate, severe disease?
Do you use some other method to
categorize patients –
early disease, established disease?
How do you
currently assess a patient’s likelihood of progression in AS?
Do you believe
that earlier intervention with biologics leads to better clinical outcomes?
If treated
early and aggressively, do you believe that the natural course of AS can be
altered?